Effect of cognitive behavior therapy for antiretroviral therapy adherence and depression among people living with HIV and depressive symptoms: A randomized controlled trial

Effect of cognitive behavior therapy for antiretroviral therapy adherence and depression among people living with HIV and depressive symptoms: A randomized controlled trial - Effect of cognitive behavior therapy for antiretroviral therapy adherence and depression among people living with HIV and depressive symptoms: A randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031442

Enrollment

150

Registered

2018-02-23

Start date

2018-05-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People living with HIV, depressive episode, ART non-adherence

Interventions

A weekly, 8-session group-based program which provide the psychoeducation of ART adherence and depression based on cognitive behavioral therapy technique Treatment as usual which include the counsel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) being HIV positive 2) Beck depression inventory II index > 10 at the baseline study (pre-threshold depression) 3) no suicidal thought and experience (questionnaire) 4) having sufficient knowledge of Myanmar language 5) available for the next 10 weeks to work on intervention

Exclusion criteria

Exclusion criteria: 1) declined to participate in this study

Design outcomes

Primary

Measure	Time frame
1) ART Adherence measured by multi-method tool (four method) at the baseline, after intervention, 3-month and 6-month follow-up 2) Severity of depression by mBDI-II 3) Severity of depression by 19-item mental health questionnaire	—

Secondary

Measure	Time frame
1) CD4 count 2) Viral load	—

Countries

Asia(except Japan)

Contacts

Public ContactKhine Lae Win

University of Tokyo Mental Health

khinelaewin@gmail.com+81-3-5841-3521

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026